Agencies can embrace the need to change—or sit back and watch their value melt away
News on Allergan, Merz, inVentiv Health and Publicis Groupe
A changing of the guard at Edelman saw Kym White move up to global practice chair for health.
WCG established a new holding company, dubbed W20, encompassing WCG and two sibling firms
Former FDA commissioner Andrew von Eschenbach has joined the Manhattan Institute to head up its Project FDA initiative.
Congressional Republicans—and a few Democrats—are pressing the attack on the Independent Payment Advisory Board for Medicare.
Apparently, unless the rules explicity prohibit a specific type of unethical behavior, you’re OK
Let clients pick and choose based on best-in-class expertise, as opposed to ‘one-stop shopping.’
Without behavioral targeting, it’s back to mass marketing using a shotgun approach
On the FDA’s warning about statin drugs
Get the most out of
Register for free and enjoy unlimited access to:
